📢 GBI Bio will be attending BioProcess International East 📢 This is a fantastic opportunity to connect with industry leaders, explore groundbreaking innovations, and engage in thought-provoking discussions that are shaping the future of biopharmaceutical development and production. 💭 Don't forget to book a meeting with the GBI Bio September 23rd to the 26th, in Boston, MA ‼ Representing Member Attending: 🙋♂️ Nicholas Filipancic, MBA, Director of Business Development For more information on the conference & to book a meeting with GBI Bio click the link below 👇 https://lnkd.in/eHWt_4cP #biologics #biotech #cdmo #BPIEast2024
GBI Bio
Biotechnology Research
Fort Lauderdale, Florida 4,993 followers
Your CDMO Partner for On-Time Process Development and cGMP Manufacturing.
About us
GBI, based near Fort Lauderdale, Florida, is a fully integrated, customer-focused cGMP Contract Development Manufacturing Organization (CDMO) of Biosimilar and innovative monoclonal antibodies, recombinant proteins, vaccines, Antibody Drug Conjugates (ADCs), and other bioconjugates. GBI offers a wide range of Single Source Solution services, including cell line development, GMP master cell banking, proof-of-concept development, cell culture, purification, and bioconjugation process development, scale-up, GLP pilot manufacturing for Tox animal studies, and cGMP manufacturing with fill & finish for human clinical trials. These core services are complemented by full support relative to assay development and qualification, analytical and microbiological Quality Control (QC), and Quality Assurance and Regulatory Affairs (QA/RA). With over 20 years of experience as an independent contract development and manufacturing service provider, GBI has worked with organizations of all sizes, from academic research institutions and virtual biotech start-ups to large, established multinational corporations.
- Website
-
https://www.gbibio.com
External link for GBI Bio
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Fort Lauderdale, Florida
- Type
- Privately Held
- Specialties
- Biosimilars, Bioconjugation, Monoclonal Antibodies, Recombinant Proteins, Cell Culture, Vaccines, Antibody Drug Conjugates, Radioimmunoconjugates, Purification, QbD, Assay Development, Process Development, GMP Manufacturing, Cell Line Development, Cell Banking, and Biologics
Locations
-
Primary
1850 NW 69th Ave
Fort Lauderdale, Florida 33313, US
Employees at GBI Bio
-
Steven Vorgity
Vice President of Finance at GBI biomanufacturing
-
Kent Payne
Life Science Executive/Board Member
-
Darrin Schellin
CEO & Board Member @ GBI Bio | Biopharmaceutical Manufacturing | Board Member, PharmaBioSource, Inc. ǀ Strategy ǀ Leadership ǀ CDMO | M & A |…
-
Jose Placeres
Production Scientist at CDS
Updates
-
📢 Exciting News ‼ 📚 GBI Bio is thrilled to share that our latest case study has been published by The Journal of Nuclear Medicine-JNM! 🎉 This publication dives deep into the complexities of antibody-chelator conjugates (ACCs), exploring innovative strategies and actionable insights that have applications in the Theranostics and other radio nuclide medical arenas. A huge thank you to our CSO, Muctarr Sesay, who authored this case study. Your dedication and expertise were instrumental in making this happen. 👏 If you're preparing your radioimmune conjugate program for clinical trials, this case study offers valuable lessons and practical takeaways that can help drive engineering your bioconjugate. Read the full case study via the link below 👇 🔗 https://lnkd.in/eQXrWJbd We look forward to hearing your thoughts and engaging in discussions on how we can continue to create solutions to the complexities of ACCs together! Feel free to contact us for CDMO services for Bioconjugation program! #CaseStudy #NewPublication #Innovation #Leadership
-
👏 Great insight provided by GBI's Director of Business Development, Nicholas Filipancic, MBA, for our upcoming conference BioProcess International East 💭 ‼
🔬 BioProcess International East is just around the corner and I am looking forward to discussing and hearing more about some key trends while attending the show with the GBI Bio team: 🌟 Efficiency Enhancements Across Bioprocessing Phases 🌟 🔬 Cell Line Development Breakthroughs: There’s been great progress in streamlining vector designs and single-cell clone selections, especially with CHO cell lines. 🚀 The recent advancements in using minipool cells to kickstart certain process development activities have significantly cut down timelines, making cell line development faster and more efficient. 🤖 Emerging Technologies: Continuous processing, automation, high-throughput experimentation, and predictive modeling are increasingly being integrated into process development and commercial manufacturing. These technologies are driving efficiency while ensuring quality, ultimately speeding up the delivery of life-saving medicines to patients. ⚛️ CMC Considerations for Radiopharmaceutical Manufacturing: As radiopharmaceuticals continue to rise, there’s a growing focus on sourcing and generating antibody or protein delivery systems, developing scalable conjugation processes for chelators or linker-payloads, and managing short half-life components. Ensuring traceability and reliable sourcing for radioactive materials is becoming ever more critical. #Bioprocessing #Biotech #Pharmaceuticals #Innovation
-
Another Member of GBI Bio has participated in Pharma's Almanac's RoundTable discussions for 2024! 💬 ✍ 👀 Click the link below to read Amita Quadros, VP of Commercial Operations, response to "How Can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?" https://lnkd.in/gNDssXH9 #biotech #cdmo #roundtablediscussion #2024
-
A Member of GBI Bio has participated in Pharma's Almanac's RoundTable discussions for 2024! 💬 ✍ 👀 Click the link below to read Robert Gustines, VP of Business Development, response to "What are the Current Investment Trends in the Pharmaceutical Industry, and How are They Influencing the Sector's Direction?" https://lnkd.in/eqGpaefY #biotech #cdmo #roundtablediscussion #2024
What are the Current Investment Trends in the Pharmaceutical Industry, and How are They Influencing the Sector’s Direction? - GBI Biomanufacturing
https://www.gbibio.com
-
GBI Bio's New Blog is Live! 📢 Authored by: Amita Quadros Titled "Emerging Trends in Bioconjugation: What the Future Holds" Topics ✍: - Advances and Challenges in Bioconjugation Development - Pathways to Overcome Challenges in Bioconjugation Development - CDMO Bioconjugation Services - Commercial Bioconjugation Services Click the link below to read the full blog! 👇 https://lnkd.in/eUq27URR #cdmo #Bioconjugation #biotech #Commercial
-
Happy Work Anniversary to James Johnson 🎉 Thank you for being part of the GBI Bio Team ‼ #workanniversary #celebrating #cdmo #biotech
-
🤔 Why Choose a U.S. Based CDMO 💭 In today's rapidly evolving biopharmaceutical landscape, partnering with the right CDMO is crucial. Here’s why: 🔹 Enhanced Security and Compliance 🔹 Streamlined Processes 🔹 Robust Infrastructure 🔹 Supply Chain Reliability 🔹 Economic Incentives 🔹 Expertise and Collaboration Partner with GBI Bio and leverage the additional benefits of 30+ years of Experience in the CDMO Space, Project Management throughout the full project timeline, Professional Expertise & Capabilities to perform Process Development to DS & DP Commercial Manufacturing all under one roof ‼ Contact our BD team Robert Gustines & Nicholas Filipancic, MBA via the link below 👇 https://lnkd.in/gRexfGHw #Biopharma #CDMO #BioSecureAct #USManufacturing #Biotech #PharmaceuticalDevelopment #SupplyChainExcellence #Innovation
-
GBI Bio's New Blog is Live! 📢 Authored by: Robert Gustines Titled "Tech Transfer: Focus on the Details" Topics ✍: - List of rationales for Technology Transfer Process - GBI's process for a Seamless Tech Transfer Process Click the link below to read the full blog! 👇 https://lnkd.in/eWpnVDvw #cdmo #techtransfer #process #biotech